3-D Matrix Reports Strong US Sales Growth, Expands Global Operations

TOKYO, Jul 17 (Pulse News Wire) – 3-D Matrix,ltd. (7777.T) reported robust sales growth in the United States during the fiscal year ending April 2026, driven by increased activity among sales staff and higher-than-usual new account openings.

In Europe and Japan, the company saw significant progress in the gastrointestinal and otolaryngology segments, though European operations showed mixed results across countries. Regarding future plans, the company expects continued strong performance in the US gastrointestinal sector, with ear, nose, and throat products also showing promising growth rates. In Europe, efforts are focused on expanding beyond the digestive health domain into areas such as urology and neurosurgery. Meanwhile, Japan's gastrointestinal market remains a key focus, despite recent stagnation.

In addition, the company outlined its strategy for enhancing shareholder value through improved investor relations activities, including more frequent meetings with institutional investors and exploring hybrid participation options for annual general meetings. The firm also detailed its approach to managing foreign exchange risks and personnel planning, aiming for a balanced increase in operating expenses to support sustainable growth. For the upcoming fiscal year, 3-D Matrix anticipates a workforce expansion to 139 employees, up from 129 at the end of April 2026. The company continues to evaluate various stockholder return strategies, including potential dividend payouts and share buybacks, while prioritizing long-term business development and operational stability.